144 related articles for article (PubMed ID: 29928999)
1. A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis.
Mitchell JM; Berzins SP; Kannourakis G
Clin Immunol; 2018 Sep; 194():19-25. PubMed ID: 29928999
[TBL] [Abstract][Full Text] [Related]
2. Foxp3
Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
[TBL] [Abstract][Full Text] [Related]
3. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cell histiocytosis in Chinese adults: absence of BRAF mutations and increased FOXP3(+) regulatory T cells.
Tong C; Jia X; Jia Y; He Y
Int J Clin Exp Pathol; 2014; 7(6):3166-73. PubMed ID: 25031736
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
Egeler RM; van Halteren AG; Hogendoorn PC; Laman JD; Leenen PJ
Immunol Rev; 2010 Mar; 234(1):213-32. PubMed ID: 20193021
[TBL] [Abstract][Full Text] [Related]
6. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
8. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
[TBL] [Abstract][Full Text] [Related]
9. Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis.
Mitchell J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Sci Rep; 2018 Nov; 8(1):16506. PubMed ID: 30405183
[TBL] [Abstract][Full Text] [Related]
10. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
[TBL] [Abstract][Full Text] [Related]
12. Neonatal and early infantile cutaneous langerhans cell histiocytosis: comparison of self-regressive and non-self-regressive forms.
Battistella M; Fraitag S; Teillac DH; Brousse N; de Prost Y; Bodemer C
Arch Dermatol; 2010 Feb; 146(2):149-56. PubMed ID: 20157025
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis in IPEX syndrome: possible role for natural regulatory T cells?
Sayar E; Uygun DF; Islek A; Hazar-Sayar E; Akkaya B; Vignoli M; Gambineri E; Yesilipek MA; Artan R
Pediatr Allergy Immunol; 2014 Oct; 25(6):601-3. PubMed ID: 24628744
[No Abstract] [Full Text] [Related]
14. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.
Annels NE; Da Costa CE; Prins FA; Willemze A; Hogendoorn PC; Egeler RM
J Exp Med; 2003 May; 197(10):1385-90. PubMed ID: 12743170
[TBL] [Abstract][Full Text] [Related]
15. The presence of cytokines in Langerhans' cell histiocytosis.
de Graaf JH; Tamminga RY; Dam-Meiring A; Kamps WA; Timens W
J Pathol; 1996 Dec; 180(4):400-6. PubMed ID: 9014861
[TBL] [Abstract][Full Text] [Related]
16. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
17. Langerhans-cell histiocytosis 'insight into DC biology'.
Laman JD; Leenen PJ; Annels NE; Hogendoorn PC; Egeler RM
Trends Immunol; 2003 Apr; 24(4):190-6. PubMed ID: 12697451
[TBL] [Abstract][Full Text] [Related]
18. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
Hage C; Willman CL; Favara BE; Isaacson PG
Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis of the female genital tract: a literature review.
Montero AJ; Díaz-Montero CM; Malpica A; Ramirez PT; Kavanagh JJ
Int J Gynecol Cancer; 2003; 13(3):381-8. PubMed ID: 12801274
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell expansion in oral and maxillofacial Langerhans cell histiocytosis.
Zhang C; Gao J; He J; Liu C; Lv X; Yin X; Deng Y; Lu Z; Tian Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):547-556. PubMed ID: 32988807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
